Flora Peyvandi Shares Study on Anticoagulants and Ischemic Stroke Risk in Cancer-Associated VTE
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism.
Ischemic stroke is a common occurrence after cancer-associated VTE and may occur more frequently in patients treated with DOACs.”
Title: Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism
Authors: Sirui Ma, Yu-Cheng Chang, Cho Han Chiang, Junmin Song, Yu-Che Lee, Ko-Yun Chang, Robert A Redd, Thita Chiasakul, Ellen P. McCarthy, Jeffrey I. Zwicker, Rushad Patell, Avi Leader
Read the full article here.
Stay informed with Hemostasis Today.
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy
-
Jun 26, 2026, 15:51Heghine Khachatryan: Willebrand Disease – Similar Bleeding Phenotype, Distinct Pathophysiology
-
Jun 26, 2026, 15:37Von Willebrand Disease: New Diagnostic Approaches
-
Jun 26, 2026, 13:58Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
-
Jun 26, 2026, 13:49Raghavendra Rao: The Surprising Link Between Chronic Venous Insufficiency and Falls
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment